Syncom Formulation (India) Ltd

NSE: SYNCOMF · BSE: 524470 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹23.22
Market cap: ₹2,183 Cr
Revenue (annual): ₹489.2 Cr
Net profit (annual): ₹76.44 Cr
P/E (TTM): 25.5×Sector 47.4×
Promoter holding: 50.57%+0.00% QoQ
FII holding: 0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 8 Financial Results 3 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

3 Apr 2026 16:07 IST BSE

Debt & Borrowing

Syncom Formulation (India) Debt & Borrowing

Syncom Formulations (India) Ltd confirmed it does not meet the SEBI criteria for 'Large Corporate' status for the financial year ended March 31, 2026. The company reported zero outstanding borrowings in its initial disclosure, making the mandatory debt market borrowing framework non-applicable.

Read the filing ↗